Fobibehandling.dk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 21.7% 18.5% 19.8% 11.4%  
Credit score (0-100)  0 4 7 5 20  
Credit rating  N/A B B B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Gross profit  0.0 -10.5 54.0 6.9 23.4  
EBITDA  0.0 -10.5 -6.3 -25.4 22.3  
EBIT  0.0 -10.5 -6.3 -25.4 22.3  
Pre-tax profit (PTP)  0.0 -10.6 -6.8 -25.6 22.3  
Net earnings  0.0 -10.6 -6.8 -25.6 17.4  
Pre-tax profit without non-rec. items  0.0 -10.6 -6.8 -25.6 22.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 49.4 42.1 16.4 33.8  
Interest-bearing liabilities  0.0 0.0 0.9 5.2 5.4  
Balance sheet total (assets)  0.0 49.4 46.0 21.7 45.7  

Net Debt  0.0 -42.5 -45.0 -11.0 -33.4  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -10.5 54.0 6.9 23.4  
Gross profit growth  0.0% 0.0% 0.0% -87.2% 239.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 49 46 22 46  
Balance sheet change%  0.0% 0.0% -6.9% -52.9% 111.0%  
Added value  0.0 -10.5 -6.3 -25.4 22.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 1.0  

Profitability 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% -11.6% -369.0% 95.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -21.3% -13.1% -75.2% 66.4%  
ROI %  0.0% -21.3% -13.6% -78.7% 73.4%  
ROE %  0.0% -21.5% -14.8% -87.6% 69.1%  

Solidity 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Equity ratio %  0.0% 100.0% 91.5% 75.9% 74.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 403.1% 719.0% 43.4% -149.4%  
Gearing %  0.0% 0.0% 2.3% 31.7% 16.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 107.8% 5.6% 0.0%  

Liquidity 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Quick Ratio  0.0 0.0 11.7 4.2 3.8  
Current Ratio  0.0 0.0 11.7 4.2 3.8  
Cash and cash equivalent  0.0 42.5 46.0 16.3 38.8  

Capital use efficiency 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 49.4 42.1 16.4 33.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/3
2021
2022/3
2022
2023/3
2023
2024/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0